Home » Topics » Regulatory » Patents

Patents
RSS

Concert Pharmaceuticals presents new PPARalpha, PPARdelta agonists

Sep. 5, 2017

PMV Pharmaceuticals describes novel compounds restoring mutant p53 function

Sep. 5, 2017

Debiopharm, Evotec describe new IDH1, IDH2 inhibitors

Sep. 4, 2017

Protein kinase inhibitors reported at Korea Institute of Science and Technology, DGMIF

Sep. 4, 2017

Sprint Bioscience discloses novel PIK3C3 and autophagy inhibitors

Sep. 4, 2017

Global Blood Therapeutics divulges novel EHMT2 inhibitors

Sep. 4, 2017

High mobility group protein B1 inhibitors disclosed by Kyungpook National University

Sep. 4, 2017

Inventisbio describes new indoleamine 2,3-dioxygenase 1 inhibitors

Sep. 4, 2017

EMBL, Savira patent compounds for treating influenza

Sep. 4, 2017

Penn State Research Foundation divulges CCK2 receptor-targeting DNA aptamers

Sep. 1, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...